Related Experiment Video

Updated: May 4, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K

You are never too old for a congenital disease!

Mukul Khanna1, Saro Sarkisian1, Phu Tran1

  • 1Department of Internal Medicine, University of Pittsburgh Medical Center - McKeesport Hospital, Pittsburgh, PA, USA.

Journal of Community Hospital Internal Medicine Perspectives
|January 7, 2014
PubMed

Insights

Congenital diseases can be missed due to rarity or delayed symptoms, impacting treatment. This case highlights a rare congenital vascular anomaly presenting in adulthood with dysphagia and chest pain.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Gastroenterology

Background:

  • Congenital diseases are often underdiagnosed due to infrequent presentation or late-onset symptoms.
  • Delayed diagnosis of congenital conditions can significantly impede timely and effective treatment strategies.

Observation:

  • A patient presented with significant dysphagia and chest pain, symptoms not immediately indicative of a congenital condition.
  • Diagnostic workup revealed an underlying congenital vascular anomaly, identified during the patient's fifth decade of life.

Findings:

  • The patient's symptoms of dysphagia and chest pain were directly attributed to a previously undetected congenital vascular anomaly.
  • This case underscores the importance of considering congenital etiologies even in adult-onset presentations.

Implications:

  • Highlights the need for heightened clinical suspicion for congenital diseases in adult patients with atypical or delayed symptom onset.
  • Emphasizes the potential for late diagnosis of congenital vascular anomalies, necessitating comprehensive diagnostic approaches.
  • Suggests that earlier detection of such anomalies could lead to improved patient outcomes and management strategies.

Keywords:
aberrant right subclavian arterybarium esophagogramchest paincongenital anomalydysphagiaextrinsic esophageal compression

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

11.1K
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

6.5K

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
94.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410